Cancer Therapy pp 216-222 | Cite as

New Cancer Treatment with Lasers — Photodynamic Therapy and Interstitial Hyperthermia

  • S. G. Bown
Conference paper


Lasers are sophisticated light sources that can deliver energy to living tissue with a great deal of precision. However, many of their current clinical applications, although more accurate than the available alternatives, are still relatively crude, and the effects are judged largely on the immediate visual changes alone. The real future of lasers in medicine lies in harnessing the precision available and applying it to biological systems. Inevitably, it is far more difficult to control all the factors that influence the nature and extent of laser effects in living tissue than it is in inanimate materials, but one can do considerably better than with other energy sources, such as diathermy. High-power lasers have an established role in clinical practice as, for example, the carbon dioxide laser in gynaecology and the neodymium yttrium aluminium garnet (YAG) laser for the endoscopic palliation of advanced obstructing tumours of the gastrointestinal tract and major airways [1].


Photodynamic Therapy Yttrium Aluminium Garnet Thermal Lesion Total Light Energy Interstitial Hyperthermia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bown SG (1986) Laser endoscopy. Br Med Bulletin 42 (3): 307–313Google Scholar
  2. 2.
    Hahn GM (1982) Hyperthermia and cancer. Plenum, New YorkGoogle Scholar
  3. 3.
    Bown SG (1983) Phototherapy of Tumors. World J Surg 7: 700–707PubMedCrossRefGoogle Scholar
  4. 4.
    Doiron D, Gomer C (eds) (1984) Porphyrin localisation and treatment of tumours. Plenum, New YorkGoogle Scholar
  5. 5.
    Dougherty TJ, Potter WR, Weishaupt R (1984) The structure of the active component of HpD. In Doiron D, Gomer C (eds) Porphyrin Localisation and Treatment of Tumours, Alan R. Liss, New York, pp 301–314Google Scholar
  6. 6.
    Spikes JD (1986) Phthalocyanines as photosensitizers in biochemical systems and for the pho- todynamic therapy of tumours. Photochem Photobiol 43 (6): 691PubMedCrossRefGoogle Scholar
  7. 7.
    Weishaupt KR, Gomer CJ, Dougherty TJ (1976) Identification of singlet oxygen as the cyto¬toxic agent in photoactivation of a murine tumour. Cancer Res 36: 2326–2329PubMedGoogle Scholar
  8. 8.
    Bown SG, Tralau CJ, Coleridge-Smith PD, Akdemir D, Wieman TJ (1986) Photodynamic therapy with porphyrin and phthalocyanine sensitization: quantitative studies in normal rat liver. Br J Cancer 54: 43–52PubMedCrossRefGoogle Scholar
  9. 9.
    Wharen RE, Anderson BAS, Laws ER (1983) Quantitation in HpD of human gliomas, experimental central nervous system tumours and normal tissues. Neurosurg 12 (4): 446CrossRefGoogle Scholar
  10. 10.
    Chaudhuri K, Goldblatt PJ, Kreimer-Birnbaum M, Keck RW, Selman SH (1986) Histological study of the effect of HpD photodynamic therapy on the rat jejunum. Cancer Res 46: 2950–2953PubMedGoogle Scholar
  11. 11.
    Okuda S, Mimura S, Otani T, Ichii M, Tatsuta M (1984) Experimental and clinical studies on HpD photodynamic therapy for upper gastrointestinal cancers. In: Andreoni A, Cubeddu R (eds) Porphyrins in tumour phototherapy, Elsevier, Amsterdam, pp 413–422Google Scholar
  12. 12.
    Gomer CJ and Dougherty TJ (1979) Determination of 3H and 14C HpD distribution in malignant and normal tissue. Cancer Res 39: 146–51PubMedGoogle Scholar
  13. 13.
    Matthewson K, Coleridge-Smith PD, O’Sullivan JP, Northfield TC, Bown SG (1987) Biological effects of intrahepatic NdYAG laser photocoagulation in rats. Gastroenterology 93: 550–557PubMedGoogle Scholar
  14. 14.
    Matthewson K, Coleridge-Smith P, Northfield TC, Bown SG (1986) Comparison of continuous wave and pulsed excitation for interstitial NdYAG laser induced hyperthermia. Laser Med Sci 1: 197–201CrossRefGoogle Scholar
  15. 15.
    Collins CM, Tralau CJ, Wieman TJ, Bown SG (1986) Histological comparison of photodynamic therapy with phthalocyanine sensitisation and thermal injury in normal rat liver. British Medical Laser Association, 4th annual congress, LondonGoogle Scholar
  16. 16.
    Barr H, Tralau CJ, MacRobert AJ, Krasner N, Boulos PB, Bown SG (1987) Photodynamic therapy in the normal rat colon with phthalocyanine sensitization. Br J Cancer 56: 111–118PubMedCrossRefGoogle Scholar
  17. 17.
    Matthewson K, Barton T, Lewin MR, O’Sullivan JP, Northfield TC, Bown SG, Low power interstitial NdYAG laser photocoagulation in normal and neoplastic rat colon. GUT 29: 27–34Google Scholar
  18. 18.
    Barr H, Tralau CJ, Boulos PB, MacRobert AJ, Tilly R, Bown SG (1988) Contrasting mechanisms of colonic collagen damage between photodynamic therapy and thermal injury. Photochem Photobiol 46: 795–800CrossRefGoogle Scholar
  19. 19.
    Tralau CJ, MacRobert AJ, Coleridge-Smith PD, Barr H, Bown SG, Photodynamic therapy with phthalocyanine sensitisation: quantitative studies in a transplantable fibrosarcoma of rats. Br J Cancer 55: 389–395Google Scholar
  20. 20.
    Henderson BW, Waldow SM, Dougherty TJ (1985) Interaction of photodynamic therapy and hyperthermia, tumour control and tumour cell survival after treatment in vivo. Lasers Surg Med 5: 139Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1989

Authors and Affiliations

  • S. G. Bown
    • 1
  1. 1.National Medical Laser CentreThe Rayne InstituteLondonUK

Personalised recommendations